Articles tagged with Cancer Patients
Researchers have identified GARP, a protein on immune cells, as a potential new target for immunotherapy against colorectal cancer. Disrupting GARP reduces tolerance and inhibits Treg cell migration to the gut, leading to reduced colon cancer development.
A new study reveals that patients with prostate, bladder, or kidney cancers who have had psychiatric care prior to treatment are at a greater risk of dying. The research also found an increased suicide risk among these patients, even after adjusting for previous mental health treatment.
A new study shows that innovative communication programs can improve patients' mental health symptoms and quality of life. The program, which involves structured conversations between clinicians and patients, results in more timely and meaningful discussions about patient values and goals.
Researchers from German Cancer Research Center have successfully reconstructed biomolecules in their mirror-image form. This breakthrough could lead to the creation of mirror-image therapeutic proteins that are protected from biological breakdown and do not provoke immune responses.
Two new studies highlight advances in lung cancer treatment. A multidisciplinary thoracic cancers symposium presents findings on local consolidative therapy linked to improved overall survival for patients with oligometastatic non-small cell lung cancer (NSCLC). Another study demonstrates the effectiveness of structured exposure to NSC...
Researchers at the University of Pittsburgh and UPMC Hillman Cancer Center have developed an AI model that can accurately identify benign nodules in low-dose CT scans, reducing false positives by up to 30%. This means patients with benign nodules won't need additional testing or biopsies, streamlining their care.
Researchers have identified two new nuclear medicine tracers that provide high-contrast images for cancer diagnosis, allowing for shorter imaging times and no diet changes. The tracers target cancer-associated fibroblasts, promoting tumor growth, migration, and progression.
A team of Australian and US researchers has identified a potential therapeutic drug target for aggressive breast cancers. The Oncomix method enabled them to 'zoom in' on genetic information from cancer patients and identify genes with distinct activity patterns, revealing five genes that promote tumour growth.
Researchers have discovered a potential treatment for cancer in patients with epidermolysis bullosa, a severe skin disease also known as butterfly disease. The new drug, rigosertib, was shown to be highly effective at killing cancer cells in preclinical studies and may target the cancer without harming healthy cells.
A study of over 675,000 cancer patients found that those with a psychiatric history were 73% more likely to die from their cancer. The risk increased with the level of psychiatric help, suggesting that stress may affect the body's biological systems.
Researchers at Huntsman Cancer Institute discovered a combination drug therapy that may effectively combat the disease. The study, led by Conan Kinsey and Martin McMahon, found a strong response in mouse models and may be a promising therapy for patients with pancreatic cancer.
Stem cell research reveals that aging brain stem cells enter a state of dormancy promoted by inflammatory signals, reducing their ability to regenerate neurons. However, blocking these inflammatory signals using antibodies increases dividing activity and improves neuron production.
Scientists at FAU create porous scaffolds using electrospinning to support ovarian follicle growth, showing promising results. The goal is to develop an ideal artificial ovary that mimics the natural environment for follicle maturity, potentially increasing fertility in cancer patients.
A new study by Colorado researchers finds that group dynamics-based exercise class increases quality of life beyond personal training for breast cancer survivors. Both groups showed similar physical gains, but the women in the group-dynamics class outpaced those in personal training.
A study of 160 breast cancer survivors found that most reported four times more positive than negative thoughts about changes they experienced due to their illness. Patients who participated in a psychological intervention program reported even more positive life changes.
Researchers found that mutations in cancer genes disrupt regulatory links between unicellular and multicellular genes, leading to widespread downstream dysregulation. The study provides a novel framework for identifying key mutations in cancer cells.
Researchers at the University of Kansas have developed a 'lab-on-a-chip' that can detect cancer in a minuscule amount of plasma, leading to timelier interventions and better outcomes for patients. The device uses a 3D nanoengineering method to mix and sense biological elements more efficiently, enabling faster and cheaper detection.
The proportion of early-stage drug trials tackling rare cancer types has increased sharply, with the analysis highlighting a changing treatment landscape. New molecularly-targeted anticancer drugs and immunotherapy are being evaluated for less common tumour types.
Researchers at UVA School of Medicine discovered a defect in killer T cells that makes them ineffective against cancer. Repairing this defect could make the cells better cancer killers.
A new AI using Network Analysis has identified nausea as a central symptom impacting various networks of cancer symptoms during chemotherapy. This analysis could help plan treatment and manage symptoms for future patients.
The growing number of cancer survivors, particularly those over 65, poses a significant challenge in delivering follow-up care due to their multiple health issues. Risk-stratified cancer follow-up care is recommended as a solution to address the supply and demand gap.
A preclinical study has identified a potential treatment strategy for low-grade gliomas, a common and lethal form of brain tumor. The researchers found that certain mutations in genes IDH1, TP53, and ATRX make glioma cells less aggressive and resistant to radiation therapy.
Research at Fred Hutchinson Cancer Center found that patients face structural and clinical barriers to participating in clinical trials, with nearly 22% deemed ineligible. The team calls for policy changes such as expanding trial locations and proactively discussing options with patients to increase access and participation.
Research reveals that patients with specific MAPK mutations are more likely to respond to immunotherapy drugs in glioblastoma. The study also found that tumors with PTEN mutations were less responsive to treatment, suggesting new targets for treatment development.
A research team at the Medical University of South Carolina has discovered a novel binding site for E1 inhibitors, which could lead to the design of more efficient anti-cancer drugs. The study reveals a new mechanism for promoting drug design and specificity.
A novel mobile application called MyPath uses AI to provide personalized guidance and support to breast cancer patients in rural Georgia. The app adapts to each stage of a patient's journey, offering relevant resources and suggestions based on their medical data and changing needs.
A new study found that kidney failure patients on dialysis and transplants have significantly higher risks of dying from cancer than the general population. Cancer deaths were mainly driven by cancers present prior to dialysis or arising after transplantation, particularly those related to immune deficiency and viral infection.
Researchers discovered that BRAF inhibitors render resistant melanoma cells more sensitive to T cell attack by increasing the expression of a protein called M6PR. This finding suggests that adoptive T cell therapy may be therapeutically useful for patients who have become resistant to BRAF inhibitors.
A new study suggests that recurring infections could lead to delayed diagnoses of bladder or kidney cancer in women. Analysis of over 100,000 people found that many with blood in their urine had no check-up after initial UTI symptoms.
Two clinical studies show that liquid biopsies can accurately track lung cancer treatment responses, detecting changes in circulating tumor DNA four weeks earlier than CT imaging. The tests provide a more accurate and noninvasive way to assess therapeutic responses, avoiding unneeded toxicity or ineffective treatments.
A Dartmouth research team has found a machine learning method to predict atypical ductal hyperplasia (ADH) upgrade to cancer. The model identifies 98% of all malignant cases prior to surgery while sparing 16% of women who would have undergone unnecessary surgery for a benign lesion.
Researchers have developed a new imaging and platelet targeting chemotherapy agent for early detection and treatment of cancers. The approach holds promise for diagnosing and treating tumors without major side effects.
A new cancer drug called tisotumab vedotin has shown significant promise in treating various types of cancer, with a response rate of up to 27% in patients with advanced, drug-resistant cancers. The treatment works by releasing a toxic substance to kill cancer cells from within and has manageable side effects.
A study led by Johns Hopkins Medicine found that immunotherapy drug pembrolizumab is more effective than traditional chemotherapy for patients with aggressive Merkel cell carcinoma. The treatment showed high response rates and durable progression-free survival in both virus-positive and virus-negative subtypes.
Researchers at Georgetown Lombardi Comprehensive Cancer Center found that immunotherapy checkpoint inhibitors are both safe and effective in treating advanced cancer patients with HIV. The therapy offers similar objective response rates as non-infected patients, with benefit also seen in Kaposi's sarcoma treatment.
A recent increase in vocal-cord cancer diagnoses among young adults, mostly non-smokers, is attributed to human papilloma virus (HPV) infection. HPV-associated strains are found in all tested samples of vocal-cord cancer from patients under 30, greatly resembling recurrent respiratory papillomatosis.
A new review highlights the need for targeted approaches to address cancer therapies' impact on bone health. Efforts to limit these effects have largely relied on anti-resorptive agents with limited assessment of fracture risk reduction.
Researchers found implicit bias and mistrust issues leading to reduced treatment rates for black patients. A new system-based intervention eliminated disparities by providing real-time transparency and enhanced patient-centered communication.
A new study published in Pediatric Blood and Cancer found that early cancer surveillance in patients with Li-Fraumeni Syndrome is cost-effective, resulting in additional years of life. The research showed a significant increase in life expectancy for high-risk patients, with healthcare costs estimated at $17,000 per year gained.
Cancer researchers have mapped oesophageal adenocarcinoma genes in unprecedented detail, unveiling more than half as potentially targetable by drugs already in trials for other cancers. This breakthrough could lead to personalized therapies and improved treatment options for patients.
Patients treated at minority-serving hospitals have only about two-thirds the odds of receiving palliative care compared to those receiving care at typical hospitals. The study found that racial and ethnic minorities are less likely to receive end-of-life palliative care than their counterparts, regardless of race or ethnicity.
Researchers found that terminally ill cancer patients who have hope, positivity and family support can live well during advanced stages. The study identified a five-phase iterative process involving struggling, accepting, living with the illness, sharing the experience, and reconstructing life.
Cardiff University researchers have identified a specific Fzd receptor called Fzd7 as the predominant Wnt receptor responsible for stem cell function in the stomach and intestine. Deleting this receptor makes gastric cells unable to divide and grow, providing a potential new therapeutic route for gastric cancers.
The SU2C Meg Vosburg T-Cell Lymphoma Dream Team is developing CAR-based immunotherapy strategies to target cancerous T cells without harming the immune system. The team aims to find a therapy that can improve outcomes in this patient population and make treatments more available.
Researchers at George Washington University Cancer Center have engineered a nanoimmunotherapy ensemble to increase the potency of immune checkpoint inhibitors in treating cancer. The goal is to convert 'cold' tumors into 'hot' tumors, which can be more responsive to immunotherapy.
A study of over 800 patients with laryngeal cancer found a significant risk of the disease associated with persistent sore throats combined with other symptoms. The research aims to improve early detection and treatment outcomes for cancer patients.
A new study found that extending medication time for varenicline to 24 weeks combined with 24 weeks of counseling sessions improves quitting success rates and reduces relapse risk in cancer patients. For those taking the medication as directed, quit rates increased significantly.
Researchers analyzed data from 622 cancer patients and found that those with tachycardia had a higher mortality rate compared to those without it. Tachycardia was a significant predictor of overall mortality regardless of cancer type, highlighting the need for co-management of heart and cancer conditions.
Researchers at MUSC identified targeting Sirt-1 as a promising approach to controlling Graft-VS-Host Disease (GVHD) in patients undergoing bone marrow transplants. This study showed that inhibiting Sirt-1 can suppress T cells leading to GVHD without affecting tumor relapse, offering new hope for improved patient outcomes.
A new recovery pathway has been implemented to reduce hospital stays after the Whipple operation by 15 days, allowing patients with pancreatic cancer to transition more quickly to the next phase of treatment. The study found that this accelerated care did not increase complication rates and improved patient outcomes.
The debate centers on renaming ultra-low risk cancers to avoid unnecessary investigations and treatments. Experts recommend recalibrating thresholds for cancer diagnosis to categorize very low risk cancers as benign, reducing anxiety and improving patient outcomes.
A Rutgers study has identified the NSD2 gene as a key indicator of prostate cancer's likelihood to spread. The gene's targeting could lead to early detection and longer patient survival rates.
A large study of cancer patients reveals a significant proportion are undiagnosed with acute and chronic hepatitis B and C. The findings suggest that universal screening for these viruses may be warranted to prevent life-threatening complications and improve treatment outcomes.
A recent study surveyed 450 oncologists in the US, revealing that most are unaware of how to treat patients with LGBTQ+ differences but are interested in learning more. The researchers recommend establishing protocols for treating LGBTQ cancer patients and providing education and training for physicians.
A new study published in the Journal of Clinical Oncology highlights gaps in attitudes, knowledge, and practices towards LGBTQ patients among oncologists. The research identified a need for education and training on LGBTQ-related issues to improve care for this patient population.
A study of over 8.6 million cancer patients found that white males, younger patients, and those with specific types of cancer were more likely to commit suicide. The researchers aim to identify high-risk patients to tailor treatments and develop survivorship programs.
Researchers at Osaka University found that mapping residual esophageal tumors can predict long-term prognosis and direct personalized treatment plans. The study identified four tumor remnant patterns, with specific associations to disease factors such as prognosis and metastasis risk.
A new SWOG Cancer Research Network study found that cancer patients with comorbidities such as hypertension or asthma are less likely to participate in clinical trials. The study suggests that allowing patients with manageable comorbidities to join trials could increase treatment opportunities for thousands of patients.
A new AI algorithm has been developed to analyze digital images of the cervix and identify precancerous changes, outperforming human experts in accuracy. The approach has the potential to transform cervical cancer screening, especially in areas with limited resources.
Researchers discovered a gene signature associated with treatment response and survival in patients with HPV-positive head and neck cancers. The biomarker distinguishes between two subgroups within HPV-positive patients, one with similar survival rates to HPV-negative cancers.